Indications & Dose:
Adult
Osteoarthritis:
PO 100-150 mg/day in divided doses (50 mg bid-tid or 75 mg bid)
Rheumatoid arthritis:
PO 150 200 mg/day in divided doses (50 mg tid-qid or 75 mg bid)
Ankylosing spondylitis:
PO 100 125 mg/day; give 25 mg qid and 25 mg hs if needed
Pain, dysmenorrhea:
PO 50 mg immediate-release tid; loading dose (100 mg) useful in some patients
SR:tabs 100 mg once daily. DS: tabs 100 mg once daily in severe cases two tablets a day.
Dispersable:tabs 100-150mg daily in two divided doses, dispersed in a glass of water, max; treatment period 3 months
75-150 mg daily in divided doses.
75 mg once daily (or twice in severe cases) for max. of 2 days, treatment should not exceed 2 days, continue if necessary tablet or suppositories
Postoperative pain:
75mg by i.v infusion ovrt 30 minutes to 2 hours, repeat if necessary 4-6 hour, max; 150mg in 24 hours
Prevention of postoperative pain:
25-50mg by iv infusion ovrt 15minutes to 1 hour than continue iv infusion of 5mg/hr, max; 150mg in24 hour.
Prevention of post-operative pain,
initially after surgery 25-50mg over 15-60 minutes than 5mg/hour for maximum 2 days.
Children
1-12 years , juvenile artheritis, by mouth/by rectum 1-3mg/kg daily in divided doses (25mg cc tablets 12.5mg and 25mg suppositories only)
Contraindications:
Bronchospasm, nasal polyps, angioedema precipitated by aspirin or other NSAIDs
Side Effects:
CNS: Anxiety, confusion, depression, dizziness, drowsiness, fatigue, insomnia, muscle weakness, nervousness, paresthesia, tremors
CV: CHF, dysrhythmias, fluid retention, hypertension, hypotension, palpitations, peripheral edema, tachycardia
EENT: Blurred vision; hearing loss, tinnitus; Ophth: anterior chamber reaction, burning, elevated intraocular pressure, irritation, keratitis, ocular allergy
GI: Anorexia, cholestatic hepatitis, constipation, cramps, diarrhea, dry mouth, flatulance, GI bleeding, jaundice, nausea, peptic ulcer, vomiting
GU: Azotemia, cystitis, dysuria, hematuria, nephrotoxicity, oliguria, UTI
HEME: Blood dyscrasias, bruising, epistaxis
RESP: Bronchospasm, dyspnea, hemoptysis, laryngeal edema, pharyngitis, rhinitis, shortness of breath
SKIN: Alopecia, erythema, petechiae, photosensitivity, pruritus, purpura, rash, sweating
Cautions:
Precautions:
: History of GI ulceration, bleeding, or perforation; renal dysfunction, hypertension or cardiac conditions aggravated by fluid retention and edema, history of liver dysfunction, history of coagulation
Interaction:
Aminoglycosides: Reduced clearance with elevated aminoglycoside levels and potential for toxicity (especially indomethacin in premature infants; other NSAIDs probably)
Anticoagulants: Excessive hypoprothrornbinemia, decreased platelet aggregation with increased risk of GI bleeding
Antihypertensives (alpha blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers, diuretics: Inhibition of antihypertensive and other favorable hemodynamic effects
Corticosteroids: Increased risk of GI ulceration
Cyclosporine: Increased nephrotoxicity risk
Lithium: Decreased clearance of lithium (mediated via prostaglandins) resulting in elevated serum lithium levels and risk of toxicity
Methotrexate: Decreased renal secretion of methotrexate resulting in elevated methotrexate levels and risk of toxicity
Phenylpropanolamine: Possible acute hypertensive reaction
Potassium-sparing diuretics: Additive hyperkalemia potential
Triamterene: Acute renal failuge reported with addition of indomethacin; caution with other NSAIDs
Warnings:
Adverse Effects:
Lactations:
Excreted in breast milk
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team